Related Experiment Videos
The pneumococcus and the mouse protection test: importance of the lag phase in vivo
Abstract:
During development of a mouse protection test with a pneumococcus type 3 we noted the importance of the immediate post-challenge lag phase of the bacteria in vivo for the effective timing of treatment with different antibiotics. The lag phase, lasting 6-8 h after intraperitoneal challenge and parallel in peritoneum and blood, was reproducible with the same and three other strains of pneumococcus type 3. Penicillin administration during the lag phase had no effect upon survival of the mice, while a significantly improved effect was obtained after treating the mice with penicillin during the bacterial growth phase. In contrast, treatment with gentamicin or erythromycin during the bacterial lag phase was significantly more effective than administration of either drug after initiation of growth of the pneumococcus.
Insights
Antibiotic effectiveness against Streptococcus pneumoniae depends on bacterial growth phase. Penicillin works best during growth, while gentamicin and erythromycin are more effective during the lag phase in mice.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Disease
Background:
- The timing of antibiotic administration is crucial for effective treatment of bacterial infections.
- Streptococcus pneumoniae is a significant human pathogen, causing various infections.
- Understanding bacterial growth dynamics in vivo can optimize therapeutic strategies.
Purpose of the Study:
- To investigate the impact of bacterial growth phase on antibiotic efficacy against Streptococcus pneumoniae in a mouse model.
- To determine the optimal timing for administering penicillin, gentamicin, and erythromycin during pneumococcal infection.
Main Methods:
- Development of a reproducible mouse protection test using Streptococcus pneumoniae type 3.
- Intraperitoneal challenge of mice and monitoring of bacterial lag phase in peritoneum and blood.
- Administration of penicillin, gentamicin, or erythromycin at different time points relative to bacterial growth.
Main Results:
- A consistent 6-8 hour lag phase for Streptococcus pneumoniae was observed post-infection in mice.
- Penicillin treatment during the lag phase showed no survival benefit, but was effective during the growth phase.
- Gentamicin and erythromycin treatments were significantly more effective when administered during the bacterial lag phase compared to the growth phase.
Conclusions:
- The bacterial lag phase is a critical window for effective antibiotic treatment of pneumococcal infections.
- Different antibiotics exhibit distinct efficacy profiles depending on the bacterial growth stage.
- Timing of antibiotic administration, considering the lag phase, is essential for optimizing therapeutic outcomes against Streptococcus pneumoniae.